Lymphoma is the third most common form of childhood cancer, after leukemia and brain tumors, and can occur at any age. There are two general types of lymphoma seen in children: Hodgkin and non-Hodgkin lymphoma. While a diagnosis of lymphoma sounds scary, innovations in treatments for this disease have made these diseases highly treatable, and curable in many instances.
Leaders in Pediatric and Young Adult Cancer Care
The University of Chicago is home to one of the most respected and recognized cancer programs in the nation. Our multidisciplinary pediatric cancer care team has the expertise and resources to provide comprehensive evaluation, treatment and management of lymphoma in infants, young children and adolescents. And the same physicians who take care of our pediatric lymphoma patients are the ones who are researching new ways to treat the disease with chemotherapy, targeted therapy and stem cell transplants
In fact, University of Chicago scientists conducted a study that is changing treatment protocols for adolescents and young adults with leukemia, lymphoma and other hematologic malignancies. This research helped lay the foundation for our Adolescent and Young Adult (AYA) Oncology Program. Serving patients ages 15 through 30 with lymphoma, the program recognizes the unique medical, social and emotional challenges that this population faces and provides specialized, coordinated care. Our team of pediatric and adult hematologists/oncologists develops individualized treatment plans and helps patients experience a life that is not limited by their diagnosis.
Ranked Among the Top Cancer Programs in the Nation
Our pediatric cancer physicians and researchers are members of the world-famous University of Chicago Comprehensive Cancer Center, a NCI-designated Comprehensive Cancer Center -- a consortium of select centers leading the nation in cancer research and providing patients with more effective health care. These teams of researchers work collaboratively, across scientific disciplines, to explore and develop innovative ways to fight and cure cancer. Because of our high level of expertise and access to the latest therapies, patients from the Midwest, the nation and around the world come to our cancer program for treatment. Frequently, our patients participate in clinical trials that use agents and approaches that are not available elsewhere. Our overall approach is to customize therapy for each patient to maximize the likelihood of cure.